rs71581787

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 3P and 20B. PM1PP2BP4_StrongBP6_Very_StrongBA1

The NM_005609.4(PYGM):​c.1184C>T​(p.Thr395Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00389 in 1,598,754 control chromosomes in the GnomAD database, including 144 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T395T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.018 ( 71 hom., cov: 31)
Exomes 𝑓: 0.0024 ( 73 hom. )

Consequence

PYGM
NM_005609.4 missense

Scores

6
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.07

Publications

8 publications found
Variant links:
Genes affected
PYGM (HGNC:9726): (glycogen phosphorylase, muscle associated) This gene encodes a muscle enzyme involved in glycogenolysis. Highly similar enzymes encoded by different genes are found in liver and brain. Mutations in this gene are associated with McArdle disease (myophosphorylase deficiency), a glycogen storage disease of muscle. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Sep 2009]
PYGM Gene-Disease associations (from GenCC):
  • glycogen storage disease V
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 11 uncertain in NM_005609.4
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 37 curated pathogenic missense variants (we use a threshold of 10). The gene has 5 curated benign missense variants. Gene score misZ: 0.046884 (below the threshold of 3.09). Trascript score misZ: 1.6804 (below the threshold of 3.09). GenCC associations: The gene is linked to glycogen storage disease V.
BP4
Computational evidence support a benign effect (MetaRNN=0.006409377).
BP6
Variant 11-64753934-G-A is Benign according to our data. Variant chr11-64753934-G-A is described in ClinVar as Benign. ClinVar VariationId is 193682.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0564 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PYGMNM_005609.4 linkc.1184C>T p.Thr395Met missense_variant Exon 10 of 20 ENST00000164139.4 NP_005600.1 P11217-1
PYGMNM_001164716.1 linkc.920C>T p.Thr307Met missense_variant Exon 8 of 18 NP_001158188.1 P11217-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PYGMENST00000164139.4 linkc.1184C>T p.Thr395Met missense_variant Exon 10 of 20 1 NM_005609.4 ENSP00000164139.3 P11217-1
PYGMENST00000377432.7 linkc.920C>T p.Thr307Met missense_variant Exon 8 of 18 2 ENSP00000366650.3 P11217-2
PYGMENST00000460413.1 linkn.261C>T non_coding_transcript_exon_variant Exon 2 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.0178
AC:
2697
AN:
151942
Hom.:
70
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0583
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0115
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00103
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00497
AC:
1112
AN:
223762
AF XY:
0.00372
show subpopulations
Gnomad AFR exome
AF:
0.0594
Gnomad AMR exome
AF:
0.00489
Gnomad ASJ exome
AF:
0.00105
Gnomad EAS exome
AF:
0.000118
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00114
Gnomad OTH exome
AF:
0.00501
GnomAD4 exome
AF:
0.00242
AC:
3507
AN:
1446694
Hom.:
73
Cov.:
37
AF XY:
0.00217
AC XY:
1556
AN XY:
718220
show subpopulations
African (AFR)
AF:
0.0622
AC:
2065
AN:
33222
American (AMR)
AF:
0.00559
AC:
239
AN:
42780
Ashkenazi Jewish (ASJ)
AF:
0.00159
AC:
41
AN:
25862
East Asian (EAS)
AF:
0.0000511
AC:
2
AN:
39102
South Asian (SAS)
AF:
0.000227
AC:
19
AN:
83844
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51848
Middle Eastern (MID)
AF:
0.00801
AC:
46
AN:
5740
European-Non Finnish (NFE)
AF:
0.000691
AC:
763
AN:
1104502
Other (OTH)
AF:
0.00555
AC:
332
AN:
59794
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
227
455
682
910
1137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0178
AC:
2705
AN:
152060
Hom.:
71
Cov.:
31
AF XY:
0.0171
AC XY:
1274
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.0583
AC:
2422
AN:
41512
American (AMR)
AF:
0.0115
AC:
176
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00103
AC:
70
AN:
67848
Other (OTH)
AF:
0.0118
AC:
25
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
137
274
410
547
684
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00765
Hom.:
46
Bravo
AF:
0.0205
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.0523
AC:
230
ESP6500EA
AF:
0.000699
AC:
6
ExAC
AF:
0.00558
AC:
675

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disease, type V Benign:4
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 14, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 25, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.15
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.40
.;T
Eigen
Benign
-0.019
Eigen_PC
Benign
0.12
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.90
D;D
MetaRNN
Benign
0.0064
T;T
MetaSVM
Benign
-0.43
T
MutationAssessor
Benign
1.5
.;L
PhyloP100
2.1
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.76
N;N
REVEL
Uncertain
0.32
Sift
Uncertain
0.017
D;D
Sift4G
Uncertain
0.0060
D;D
Polyphen
0.036
.;B
Vest4
0.38
MVP
0.94
MPC
0.49
ClinPred
0.017
T
GERP RS
5.0
Varity_R
0.10
gMVP
0.47
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71581787; hg19: chr11-64521406; API